Advances in Cardiovascular Biomarker Discovery
Cardiovascular diseases are the leading causes of mortality worldwide. Among them, hypertension and its pathological complications pose a major risk for the development of other cardiovascular diseases, including heart failure and stroke. Identifying novel and early stage biomarkers of hypertension...
Main Authors: | Crystal M. Ghantous, Layla Kamareddine, Rima Farhat, Fouad A. Zouein, Stefania Mondello, Firas Kobeissy, Asad Zeidan |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-11-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/8/12/552 |
Similar Items
-
Unveiling a Biomarker Signature of Meningioma: The Need for a Panel of Genomic, Epigenetic, Proteomic, and RNA Biomarkers to Advance Diagnosis and Prognosis
by: Reem Halabi, et al.
Published: (2023-11-01) -
Circulating miRNA-21 is an innovative biomarker for cardiovascular events in erectile dysfunction patients
by: Laura Agulló, et al.
Published: (2024-03-01) -
Recent Highlights of Research on miRNAs as Early Potential Biomarkers for Cardiovascular Complications of Type 2 Diabetes Mellitus
by: Agnieszka Bielska, et al.
Published: (2021-03-01) -
MicroRNAs in Cancer and Cardiovascular Disease
by: Mirolyuba Ilieva, et al.
Published: (2022-11-01) -
Multi-Omics Identifies Circulating miRNA and Protein Biomarkers for Facioscapulohumeral Dystrophy
by: Christopher R. Heier, et al.
Published: (2020-11-01)